rel-(2S,3S)-1-(tert-butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid

Catalog No. :
ACGYUS519
CAS No. :
828300-45-4
Molecular Formula :
C12H21NO4
Molecular Weight :
243.30

IUPAC Name:(2R,3R)-1-(tert-butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid

rel-(2S,3S)-1-(tert-butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$306.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(2S,3S)-1-(tert-butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid
IUPAC Name(2R,3R)-1-(tert-butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid
MDL No.MFCD28505765
Molecular FormulaC12H21NO4
Molecular Weight243.30
SMILESO=C([C@H]1[C@@H](C)N(C(OC(C)(C)C)=O)CCC1)O
InChI KeyTZNCDXAIDIETKV-RKDXNWHRSA-N
Synonym2S,3S-1-BOC-2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID;cis-1-Boc-2-methyl-piperidine-3-carboxylic acid;rel-(2R,3R)-1-(tert-Butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid;1,3-Piperidinedicarboxylic acid, 2-methyl-, 1-(1,1-dimethylethyl) ester, (2R,3R)-rel-;rel-(2S,3S)-1-(tert-butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid;Cis-1-(tert-butoxycarbonyl)-2-methylpiperidine-3-carboxylic acid
CAS No.828300-45-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACGYUS519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGYUS519 route product structure diagram
    ACGYUS519828300-45-4
Inquiry

2. ACGYUS519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGYUS519 route product structure diagram
    ACGYUS519828300-45-4
Inquiry

Comments (0)